Martin Rickenbach

12.2k total citations · 3 hit papers
117 papers, 7.8k citations indexed

About

Martin Rickenbach is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Martin Rickenbach has authored 117 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 41 papers in Virology and 29 papers in Emergency Medicine. Recurrent topics in Martin Rickenbach's work include HIV/AIDS Research and Interventions (54 papers), HIV/AIDS drug development and treatment (44 papers) and HIV Research and Treatment (41 papers). Martin Rickenbach is often cited by papers focused on HIV/AIDS Research and Interventions (54 papers), HIV/AIDS drug development and treatment (44 papers) and HIV Research and Treatment (41 papers). Martin Rickenbach collaborates with scholars based in Switzerland, France and United Kingdom. Martin Rickenbach's co-authors include Bernard Hirschel, Enos Bernasconi, Hansjakob Furrer, Bruno Ledergerber, Manuel Battegay, Rainer Weber, Pietro Vernazza, Matthias Egger, Matthias Cavassini and Markus Flepp and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Martin Rickenbach

117 papers receiving 7.5k citations

Hit Papers

Cancer Risk in the Swiss HIV Cohort Study: Ass... 1987 2026 2000 2013 2005 1997 1987 200 400 600

Peers

Martin Rickenbach
Jack Fuhrer United States
Alexandra Calmy Switzerland
Cynthia L. Gibert United States
Mark O. Loveless United States
Diane Aschman United States
Olivia Keiser Switzerland
Colette Smith United Kingdom
Martin Rickenbach
Citations per year, relative to Martin Rickenbach Martin Rickenbach (= 1×) peers Court Pedersen

Countries citing papers authored by Martin Rickenbach

Since Specialization
Citations

This map shows the geographic impact of Martin Rickenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Rickenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Rickenbach more than expected).

Fields of papers citing papers by Martin Rickenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Rickenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Rickenbach. The network helps show where Martin Rickenbach may publish in the future.

Co-authorship network of co-authors of Martin Rickenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Rickenbach. A scholar is included among the top collaborators of Martin Rickenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Rickenbach. Martin Rickenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bihl, Florian, G Martinetti, Gilles Wandeler, et al.. (2015). HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons. BMC Gastroenterology. 15(1). 79–79. 14 indexed citations
2.
Worm, Signe Westring, Nina Friis‐Møller, Mathias Bruyand, et al.. (2010). High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. AIDS. 24(3). 427–435. 67 indexed citations
3.
Sullivan, Sheena G., Hans H. Hirsch, Silvia Franceschi, et al.. (2010). Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study. AIDS. 24(14). 2245–2252. 20 indexed citations
4.
Glass, Tracy R., Manuel Battegay, Matthias Cavassini, et al.. (2010). Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(2). 197–203. 90 indexed citations
5.
Franceschi, Silvia, M. Lise, Gary M. Clifford, et al.. (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer. 103(3). 416–422. 221 indexed citations
6.
Ledergerber, Bruno, Matthias Cavassini, Manuel Battegay, et al.. (2010). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study*. HIV Medicine. 12(5). 279–288. 15 indexed citations
7.
Clifford, Gary M., Martin Rickenbach, M. Lise, et al.. (2009). Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood. 113(23). 5737–5742. 76 indexed citations
8.
Spicher, Virginie Masserey, et al.. (2009). Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. Journal of Viral Hepatitis. 16(9). 644–649. 13 indexed citations
9.
Wolbers, Marcel, H C Bucher, Hansjakob Furrer, et al.. (2008). Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Medicine. 9(6). 397–405. 92 indexed citations
10.
Kaufmann, Gilbert R., H Furrer, Bruno Ledergerber, et al.. (2005). Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy. Clinical Infectious Diseases. 41(3). 361–372. 245 indexed citations
11.
Glass, Tracy R., Jim Young, Pietro Vernazza, et al.. (2004). Is unsafe sexual behaviour increasing among HIV-infected individuals?. AIDS. 18(12). 1707–1714. 30 indexed citations
12.
Staehelin, Cornelia, et al.. (2004). Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: A Single Center Study of Epidemiologic Migration-Specific and Clinical Features. AIDS Patient Care and STDs. 18(11). 665–675. 28 indexed citations
13.
Fontas, Éric, Frank van Leth, Caroline Sabin, et al.. (2004). Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?. The Journal of Infectious Diseases. 189(6). 1056–1074. 274 indexed citations
14.
Keiser, Olivia, Patrick Taffé, Marcel Zwahlen, et al.. (2004). All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population. AIDS. 18(13). 1835–1843. 74 indexed citations
15.
Opravil, Milos, Bruno Ledergerber, Hansjakob Furrer, et al.. (2002). Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l. AIDS. 16(10). 1371–1381. 92 indexed citations
16.
Bassetti, Stefano, Manuel Battegay, Martin Rickenbach, et al.. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued ?. IRIS. 38 indexed citations
17.
Paccaud, Fred, et al.. (1997). Trends in Cardiovascular Risk Factors (1984–1993) in a Swiss Region: Results of Three Population Surveys. Preventive Medicine. 26(4). 523–533. 78 indexed citations
18.
Wietlisbach, Vincent, Martin Rickenbach, M. Bérode, & Michel Guillemin. (1995). Time Trend and Determinants of Blood Lead Levels in a Swiss Population over a Transition Period (1984-1993) from Leaded to Unleaded Gasoline Use. Environmental Research. 68(2). 82–90. 55 indexed citations
19.
Marti, B, et al.. (1990). [Sports correlate with positive living habits. Results from the population survey the Swiss MONICA project].. PubMed. 38(2). 71–7. 2 indexed citations
20.
Grob, P. J., Martin Rickenbach, Susanne Wagner, et al.. (1983). An account of a pilot hepatitis B vaccination programme for high-risk individuals in Zürich. Journal of Infection. 7. 85–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026